Survey respondents described generally poor health-related quality of life (QoF) that was characterized as being more severe with a skin-specific instrument than with a generic health-related QoF index.
Brad Rovin, MD, and Richard Furie, MD, discussed the merits of dual therapy with voclosporin or belimumab in lupus nephritis but said response rates leave a lot of room for improvement.